Redmile Group, Jeremy Green disclose 9.99% stake in ADC Therapeutics (ADCT)
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
ADC Therapeutics (Common Shares) Schedule 13G/A discloses that Redmile Group, LLC and affiliate Jeremy C. Green beneficially own 12,692,841 shares, equal to 9.99% of the class under the filing's calculation. The report attributes 10,276,407 shares (8.1%) to RedCo II Master Fund, L.P. Holdings include 11,110 shares issuable upon exercise of certain warrants subject to a Beneficial Ownership Limitation and a Beneficial Ownership Blocker that prevents exercises pushing ownership above 9.99%. The filing ties percentages to 127,044,356 shares outstanding as of March 2, 2026 (plus the 11,110 warrant-limited shares).
Positive
- None.
Negative
- None.
Key Figures
Redmile beneficial ownership: 12,692,841 shares
Redmile ownership percent: 9.99%
RedCo II beneficial ownership: 10,276,407 shares
+4 more
7 metrics
Redmile beneficial ownership
12,692,841 shares
As of April 6, 2026; reported beneficial ownership
Redmile ownership percent
9.99%
Percentage based on 127,044,356 shares outstanding as of March 2, 2026 plus 11,110 warrant-limited shares
RedCo II beneficial ownership
10,276,407 shares
As of April 6, 2026; reported for RedCo II Master Fund, L.P.
RedCo II ownership percent
8.1%
Percentage based on same outstanding-share base
Shares outstanding used
127,044,356 shares
Outstanding as of March 2, 2026 per ADC Therapeutics Form 10-K
Warrant-limited shares
11,110 shares
Issuable upon exercise of certain warrants subject to Beneficial Ownership Limitation
Potential warrant issuable (Redmile)
27,743,685 shares
Maximum shares issuable upon exercise of warrants subject to Blocker (subject to limitation)
Key Terms
Beneficial Ownership Limitation, Beneficial Ownership Blocker, Warrants, Beneficially owned
4 terms
Beneficial Ownership Limitation regulatory
"to the extent that after giving effect to such issuance after exercise, the holder ... would beneficially own in excess of 9.99%"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Beneficial Ownership Blocker regulatory
"the Beneficial Ownership Blocker that prevents exercises pushing ownership above 9.99%"
Warrants financial
"pre-funded warrants to purchase Common Stock (the "Warrants")"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
Beneficially owned regulatory
"may be deemed beneficially owned by Redmile Group, LLC as investment manager"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
FAQ
What stake does Redmile Group hold in ADC Therapeutics (ADCT)?
Redmile Group reports beneficial ownership of 12,692,841 shares, representing 9.99% of the class. The amount includes 12,681,731 shares held by Redmile-managed funds plus 11,110 warrant‑issuable shares counted under the ownership limiter.
What is the Beneficial Ownership Limitation described in the filing?
The filing states a 9.99% Beneficial Ownership Limitation that prevents warrant exercises that would cause ownership above that threshold. The limiter may be changed by a holder upon 61 days' notice to the issuer.